Potential clinical benefits of warfarin in end‐stage cancers: A retrospective analysis

BACKGROUND AND AIMS: Coagulopathy and thromboembolism are common comorbidities in cancer, and anticoagulants, such as warfarin, are needed in specific situations. This study aimed to determine the clinical relevance of prothrombin time (PT) monitoring and the clinical usefulness of warfarin in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Imataki, Osamu, Arai, Takeshi, Uemura, Makiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871091/
https://www.ncbi.nlm.nih.gov/pubmed/36704424
http://dx.doi.org/10.1002/hsr2.956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871091/
https://www.ncbi.nlm.nih.gov/pubmed/36704424
http://dx.doi.org/10.1002/hsr2.956

Ejemplares similares